Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pharmaceutical composition for treating sequela of apoplexy

A technology for sequelae of stroke and medicine, which is applied in the direction of medicine combination, medical formula, plant raw materials, etc., and can solve the problems of small stimulation of acupoints, human side effects, easy rebound, etc.

Inactive Publication Date: 2018-03-20
NANJING DUOLING BIOLOGICAL TECH
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the past, it was well known that Western medicine had little effect on stroke sequelae for more than one year; in traditional Chinese medicine, Chinese patent medicine powder was used internally and externally combined with acupuncture to treat hemiplegia and pain. The differences in types, dosage forms and patients’ gastrointestinal tract absorption function cannot make the active ingredients of the medicine concentrate and penetrate into the body, resulting in a great waste of medicine. Moreover, some medicines have relatively large toxic and side effects on the human body; traditional acupuncture ( Acupuncture and moxibustion) have too little stimulation on the acupoints of the patient's body. Acupuncture and traditional Chinese medicine can't achieve the effect of two in one, which not only disperses their respective curative effects, but also makes it difficult to effectively exert the potential functions of acupuncture and medicine.
At present, patients with stroke sequelae are generally still treated with the same drugs as when they were suffering from stroke, and combined with auxiliary rehabilitation therapy to restore function if conditions permit, but generally speaking, the effect is not very good, and the rehabilitation effect is not ideal. The effect is slow, and the time is long, easy to rebound

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating sequela of apoplexy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Weigh each raw material of the present invention according to the following parts by weight: 10 parts of panax notoginseng, 10 parts of Yulang umbrella, 10 parts of turmeric, 10 parts of Dinggongteng, 20 parts of astragalus, 20 parts of Ivy clover, 10 parts of polygala, 10 parts of Polygonatum, 1 bird's nest acid -5 parts, 10 parts of walnut kernel, 5 parts of Ding Gong vine, 3 parts of agarwood, 10 parts of Ganoderma lucidum, 10 parts of Salvia miltiorrhiza, 10 parts of Gastrodia elata, 10 parts of dracaena genus, 10 parts of mountain green tea, 2 parts of Phnom Penh leech.

[0013] Preparation method: Take the above medicinal materials according to the proportion, add 10 times the volume (V / W) of water, heat at 100°C and concentrate to one-fifth of the original volume, then filter to obtain.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine for treating sequela of apoplexy, containing the following traditional Chinese medicine components in weight ratio: pseudo-ginseng, Yulangsan, turmeric, erycibe obtusifolia, astragalus membranaceus, illigera trifoliata, polygala tenuifolia, polygonatum sibiricum, sialic acid, persian walnut seed, agilawood, ganoderma lucidum, salvia miltiorrhiza, gastrodia elata, dracaena cochinchinensis, folium ilicis hainanensis and golden-side leeches. The pharmaceutical composition can relieve the pain of a patient, reduce fatality rate and disability rate, and improve the quality of life, has no toxic or side effect, treats both symptoms and root causes, and has an important clinical value for preventing and treating stroke.

Description

technical field [0001] The invention relates to a medicine for treating stroke sequelae, belonging to the field of traditional Chinese medicine. Background technique [0002] Stroke, as defined by traditional Chinese medicine, is a cerebrovascular disease. It is mostly caused by fatigue, internal injury, worry, anger, or addiction to delicious food, tobacco and alcohol when the human body is deficient in qi and blood. Many stroke patients who were not cured at that time left sequelae, manifested as hemiplegia, numbness in one side of the body, silent or awkward speech, crooked mouth and eyes, etc. In the past, it was well known that Western medicine had little effect on stroke sequelae for more than one year; in traditional Chinese medicine, Chinese patent medicine powder was used internally and externally combined with acupuncture to treat hemiplegia and pain. The differences in types, dosage forms and patients’ gastrointestinal tract absorption function cannot make the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P9/10A61P25/02A61K35/62A61K35/57
CPCA61K35/57A61K35/62A61K36/074A61K36/185A61K36/258A61K36/39A61K36/48A61K36/481A61K36/52A61K36/537A61K36/69A61K36/835A61K36/88A61K36/8969A61K36/8988A61K36/9066A61K2300/00
Inventor 付书婕巫玲玲蒋伟哲蒋敏捷蒋群哲周媚张卓
Owner NANJING DUOLING BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products